Product Information
FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.5791 per EA under NDC 68462016630. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on Jun 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462016630
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FINGOLIMOD HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207985FDA Approved
6/18/2020
TE Code
AB
On Market Since
9/28/2022
Pharmacological Classes
Price Statistics
The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 159 times since Sep 20, 2023, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5791 per EA |
|---|---|
| All-time high | $10.0429 (May 15, 2024) |
| All-time low | $1.5791 (Sep 23, 2026) |
| 52-week high | $5.7374 |
| 52-week low | $1.5791 |
| Median price | $5.8275 |
| Average price | $6.8897 |
| Largest weekly change | -27.4% (Jul 22, 2026) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fingolimod market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fingolimod market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sphingosine 1-phosphate Receptor Modulator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.5791 per EA (NDC 68462016630), effective Sep 30, 2026.
How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 83.8%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?
Since Sep 20, 2023, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $1.5791 (Sep 23, 2026) to a high of $10.0429 (May 15, 2024), with a median of $5.8275 per EA.
Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of FINGOLIMOD 0.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FINGOLIMOD 0.5 MG CAPSULE?
FINGOLIMOD 0.5 MG CAPSULE (NDC 68462016630) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.